Rotondi, M., Molteni, M., Leporati, P., Capelli, V., Marinò, M., & Chiovato, L. (2017). Autoimmune Thyroid Diseases in Patients Treated with Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response. Front Endocrinol (Lausanne).
Citación estilo ChicagoRotondi, Mario, Martina Molteni, Paola Leporati, Valentina Capelli, Michele Marinò, and Luca Chiovato. "Autoimmune Thyroid Diseases in Patients Treated With Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response." Front Endocrinol (Lausanne) 2017.
Cita MLARotondi, Mario, et al. "Autoimmune Thyroid Diseases in Patients Treated With Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response." Front Endocrinol (Lausanne) 2017.